Search

everythinglearnresearchcommunity

for

Search:↓

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Electric pulse treatments for breast cancer show promise in being safer and more effective, with fewer side effects.

The article concludes that understanding the causes of hair loss and using continuous treatments like minoxidil and finasteride can help manage it, despite potential side effects.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

A rare scalp condition mainly in older women can be treated with various alternatives to steroids, which may have fewer side effects.

Multiple eye conditions were studied, highlighting the importance of various imaging methods for diagnosis, the vision side effects of drugs tamoxifen and Propecia, and the usefulness of optical coherence tomography for diagnosing and monitoring macular and retinal diseases.

Stereotactic Radiosurgery is an effective non-invasive treatment for cerebral AVM, with successful outcomes and minimal side effects.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Testosterone therapy can help women with androgen deficiency by improving energy, sex drive, and bone health with few side effects.

People with certain allergic conditions or higher white blood cell counts have more severe hair loss, and treating hair and nail side effects early in melanoma therapy can improve quality of life.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

Microneedles can cause side effects like infection and allergic reactions, and precautions like test spots and sunscreen are recommended.

Biobran MGN-3 reduces chemotherapy side effects and improves quality of life for breast cancer patients.

Understanding and managing side effects of hedgehog pathway inhibitors can improve treatment for advanced basal cell carcinoma.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

Guduchi and Yashtimadhu can reduce chemotherapy side effects.

Systemic therapies improve nail psoriasis but have high side effects; more research is needed.

Nanoemulsions can effectively treat skin cancer with fewer side effects.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

Nivolumab can cause hair loss as a rare side effect.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

New cancer treatments aim to reduce side effects and improve effectiveness.

Bromhexine and spironolactone together reduced COVID-19 symptoms and hospitalization time without side effects.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

The treatment improved survival and controlled cancer spread but required managing side effects like rashes.

Nanotechnology can improve cervical cancer treatment by targeting drugs better and reducing side effects.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Extending androgen suppression before radiotherapy offers no extra survival benefit for intermediate-risk prostate cancer.